Isthmus Partners’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.85M | Buy |
132,125
+509
| +0.4% | +$11K | 0.33% | 81 |
|
|
2025
Q1 | $3.01M | Sell |
131,616
-168
| -0.1% | -$3.84K | 0.38% | 68 |
|
|
2024
Q4 | $3.42M | Sell |
131,784
-263
| -0.2% | -$6.83K | 0.42% | 61 |
|
|
2024
Q3 | $3.31M | Sell |
132,047
-33,200
| -20% | -$831K | 0.39% | 65 |
|
|
2024
Q2 | $3.54M | Buy |
165,247
+42,265
| +34% | +$906K | 0.42% | 71 |
|
|
2024
Q1 | $2.28M | Buy |
122,982
+45,900
| +60% | +$851K | 0.26% | 102 |
|
|
2023
Q4 | $1.25M | Buy |
77,082
+9,025
| +13% | +$147K | 0.16% | 108 |
|
|
2023
Q3 | $940K | Buy |
68,057
+6,171
| +10% | +$85.2K | 0.14% | 117 |
|
|
2023
Q2 | $1.37M | Sell |
61,886
-128
| -0.2% | -$2.83K | 0.19% | 103 |
|
|
2023
Q1 | $1.35M | Buy |
62,014
+1,469
| +2% | +$32K | 0.19% | 105 |
|
|
2022
Q4 | $1.1M | Buy |
60,545
+244
| +0.4% | +$4.44K | 0.17% | 108 |
|
|
2022
Q3 | $1.37M | Buy |
60,301
+3,178
| +6% | +$72.3K | 0.24% | 92 |
|
|
2022
Q2 | $789K | Buy |
57,123
+5,759
| +11% | +$79.5K | 0.15% | 107 |
|
|
2022
Q1 | $1.17M | Buy |
51,364
+23,608
| +85% | +$537K | 0.19% | 102 |
|
|
2021
Q4 | $1.03M | Sell |
27,756
-48
| -0.2% | -$1.79K | 0.17% | 106 |
|
|
2021
Q3 | $1.18M | Sell |
27,804
-21,353
| -43% | -$904K | 0.21% | 101 |
|
|
2021
Q2 | $2.19M | Buy |
49,157
+26
| +0.1% | +$1.16K | 0.39% | 58 |
|
|
2021
Q1 | $1.77M | Sell |
49,131
-1,868
| -4% | -$67.3K | 0.32% | 70 |
|
|
2020
Q4 | $2.03M | Sell |
50,999
-9,145
| -15% | -$365K | 0.41% | 49 |
|
|
2020
Q3 | $1.74M | Buy |
60,144
+3,097
| +5% | +$89.6K | 0.41% | 47 |
|
|
2020
Q2 | $933K | Buy |
57,047
+6,632
| +13% | +$108K | 0.23% | 87 |
|
|
2020
Q1 | $479K | Sell |
50,415
-2,992
| -6% | -$28.4K | 0.15% | 100 |
|
|
2019
Q4 | $864K | Buy |
53,407
+36,800
| +222% | +$595K | 0.2% | 97 |
|
|
2019
Q3 | $276K | Buy |
+16,607
| New | +$276K | 0.07% | 130 |
|